Carbon Biosciences
Pre-clinicalDevelops novel parvovirus-based gene therapies for cystic fibrosis and other genetic diseases.
Founded
2019
Focus
RNA & Gene Therapy
About
Develops novel parvovirus-based gene therapies for cystic fibrosis and other genetic diseases.
Funding History
2Total raised: $76M
Series A$38MAgent CapitalJan 15, 2022
Seed$38MAgent CapitalOct 15, 2021
Company Info
TypePrivate
Founded2019
LocationWaltham, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile